The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Extracorporeal Membrane Oxygenation System Market Research Report 2025
Synopsis
The global Extracorporeal Membrane Oxygenation System market was valued at US$ 364.7 million in 2023 and is anticipated to reach US$ 501.5 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Extracorporeal Membrane Oxygenation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracorporeal Membrane Oxygenation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Extracorporeal Membrane Oxygenation System include Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical and ALung Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Membrane Oxygenation System.
Report Scope
The Extracorporeal Membrane Oxygenation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracorporeal Membrane Oxygenation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Membrane Oxygenation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Getinge Group
Medtronic plc
LivaNova PLC
XENIOS AG
Terumo Corporation
MicroPort Scientific Corporation
NIPRO Corporation
OriGen Biomedical
ALung Technologies
EUROSETS S.r.l.
Segment by Type
Veno-Arterial (VA)
Veno-Venous (VV)
Arterio-Venous (AV)
Segment by Application
Newborn
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Extracorporeal Membrane Oxygenation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Extracorporeal Membrane Oxygenation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Extracorporeal Membrane Oxygenation System market was valued at US$ 364.7 million in 2023 and is anticipated to reach US$ 501.5 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Extracorporeal Membrane Oxygenation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracorporeal Membrane Oxygenation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Extracorporeal Membrane Oxygenation System include Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical and ALung Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Membrane Oxygenation System.
Report Scope
The Extracorporeal Membrane Oxygenation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracorporeal Membrane Oxygenation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Membrane Oxygenation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Getinge Group
Medtronic plc
LivaNova PLC
XENIOS AG
Terumo Corporation
MicroPort Scientific Corporation
NIPRO Corporation
OriGen Biomedical
ALung Technologies
EUROSETS S.r.l.
Segment by Type
Veno-Arterial (VA)
Veno-Venous (VV)
Arterio-Venous (AV)
Segment by Application
Newborn
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Extracorporeal Membrane Oxygenation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Extracorporeal Membrane Oxygenation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Extracorporeal Membrane Oxygenation System Market Overview
1.1 Product Overview and Scope of Extracorporeal Membrane Oxygenation System
1.2 Extracorporeal Membrane Oxygenation System Segment by Type
1.2.1 Global Extracorporeal Membrane Oxygenation System Market Value Comparison by Type (2024-2030)
1.2.2 Veno-Arterial (VA)
1.2.3 Veno-Venous (VV)
1.2.4 Arterio-Venous (AV)
1.3 Extracorporeal Membrane Oxygenation System Segment by Application
1.3.1 Global Extracorporeal Membrane Oxygenation System Market Value by Application: (2024-2030)
1.3.2 Newborn
1.3.3 Children
1.3.4 Adult
1.4 Global Extracorporeal Membrane Oxygenation System Market Size Estimates and Forecasts
1.4.1 Global Extracorporeal Membrane Oxygenation System Revenue 2019-2030
1.4.2 Global Extracorporeal Membrane Oxygenation System Sales 2019-2030
1.4.3 Global Extracorporeal Membrane Oxygenation System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Extracorporeal Membrane Oxygenation System Market Competition by Manufacturers
2.1 Global Extracorporeal Membrane Oxygenation System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Extracorporeal Membrane Oxygenation System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Extracorporeal Membrane Oxygenation System Average Price by Manufacturers (2019-2024)
2.4 Global Extracorporeal Membrane Oxygenation System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Extracorporeal Membrane Oxygenation System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Extracorporeal Membrane Oxygenation System, Product Type & Application
2.7 Extracorporeal Membrane Oxygenation System Market Competitive Situation and Trends
2.7.1 Extracorporeal Membrane Oxygenation System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Extracorporeal Membrane Oxygenation System Players Market Share by Revenue
2.7.3 Global Extracorporeal Membrane Oxygenation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Extracorporeal Membrane Oxygenation System Retrospective Market Scenario by Region
3.1 Global Extracorporeal Membrane Oxygenation System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Extracorporeal Membrane Oxygenation System Global Extracorporeal Membrane Oxygenation System Sales by Region: 2019-2030
3.2.1 Global Extracorporeal Membrane Oxygenation System Sales by Region: 2019-2024
3.2.2 Global Extracorporeal Membrane Oxygenation System Sales by Region: 2025-2030
3.3 Global Extracorporeal Membrane Oxygenation System Global Extracorporeal Membrane Oxygenation System Revenue by Region: 2019-2030
3.3.1 Global Extracorporeal Membrane Oxygenation System Revenue by Region: 2019-2024
3.3.2 Global Extracorporeal Membrane Oxygenation System Revenue by Region: 2025-2030
3.4 North America Extracorporeal Membrane Oxygenation System Market Facts & Figures by Country
3.4.1 North America Extracorporeal Membrane Oxygenation System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Extracorporeal Membrane Oxygenation System Sales by Country (2019-2030)
3.4.3 North America Extracorporeal Membrane Oxygenation System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Extracorporeal Membrane Oxygenation System Market Facts & Figures by Country
3.5.1 Europe Extracorporeal Membrane Oxygenation System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Extracorporeal Membrane Oxygenation System Sales by Country (2019-2030)
3.5.3 Europe Extracorporeal Membrane Oxygenation System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracorporeal Membrane Oxygenation System Market Facts & Figures by Country
3.6.1 Asia Pacific Extracorporeal Membrane Oxygenation System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Extracorporeal Membrane Oxygenation System Sales by Country (2019-2030)
3.6.3 Asia Pacific Extracorporeal Membrane Oxygenation System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Extracorporeal Membrane Oxygenation System Market Facts & Figures by Country
3.7.1 Latin America Extracorporeal Membrane Oxygenation System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Extracorporeal Membrane Oxygenation System Sales by Country (2019-2030)
3.7.3 Latin America Extracorporeal Membrane Oxygenation System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Facts & Figures by Country
3.8.1 Middle East and Africa Extracorporeal Membrane Oxygenation System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Extracorporeal Membrane Oxygenation System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Extracorporeal Membrane Oxygenation System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Extracorporeal Membrane Oxygenation System Sales by Type (2019-2030)
4.1.1 Global Extracorporeal Membrane Oxygenation System Sales by Type (2019-2024)
4.1.2 Global Extracorporeal Membrane Oxygenation System Sales by Type (2025-2030)
4.1.3 Global Extracorporeal Membrane Oxygenation System Sales Market Share by Type (2019-2030)
4.2 Global Extracorporeal Membrane Oxygenation System Revenue by Type (2019-2030)
4.2.1 Global Extracorporeal Membrane Oxygenation System Revenue by Type (2019-2024)
4.2.2 Global Extracorporeal Membrane Oxygenation System Revenue by Type (2025-2030)
4.2.3 Global Extracorporeal Membrane Oxygenation System Revenue Market Share by Type (2019-2030)
4.3 Global Extracorporeal Membrane Oxygenation System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Extracorporeal Membrane Oxygenation System Sales by Application (2019-2030)
5.1.1 Global Extracorporeal Membrane Oxygenation System Sales by Application (2019-2024)
5.1.2 Global Extracorporeal Membrane Oxygenation System Sales by Application (2025-2030)
5.1.3 Global Extracorporeal Membrane Oxygenation System Sales Market Share by Application (2019-2030)
5.2 Global Extracorporeal Membrane Oxygenation System Revenue by Application (2019-2030)
5.2.1 Global Extracorporeal Membrane Oxygenation System Revenue by Application (2019-2024)
5.2.2 Global Extracorporeal Membrane Oxygenation System Revenue by Application (2025-2030)
5.2.3 Global Extracorporeal Membrane Oxygenation System Revenue Market Share by Application (2019-2030)
5.3 Global Extracorporeal Membrane Oxygenation System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Getinge Group
6.1.1 Getinge Group Corporation Information
6.1.2 Getinge Group Description and Business Overview
6.1.3 Getinge Group Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Getinge Group Extracorporeal Membrane Oxygenation System Product Portfolio
6.1.5 Getinge Group Recent Developments/Updates
6.2 Medtronic plc
6.2.1 Medtronic plc Corporation Information
6.2.2 Medtronic plc Description and Business Overview
6.2.3 Medtronic plc Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic plc Extracorporeal Membrane Oxygenation System Product Portfolio
6.2.5 Medtronic plc Recent Developments/Updates
6.3 LivaNova PLC
6.3.1 LivaNova PLC Corporation Information
6.3.2 LivaNova PLC Description and Business Overview
6.3.3 LivaNova PLC Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LivaNova PLC Extracorporeal Membrane Oxygenation System Product Portfolio
6.3.5 LivaNova PLC Recent Developments/Updates
6.4 XENIOS AG
6.4.1 XENIOS AG Corporation Information
6.4.2 XENIOS AG Description and Business Overview
6.4.3 XENIOS AG Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 XENIOS AG Extracorporeal Membrane Oxygenation System Product Portfolio
6.4.5 XENIOS AG Recent Developments/Updates
6.5 Terumo Corporation
6.5.1 Terumo Corporation Corporation Information
6.5.2 Terumo Corporation Description and Business Overview
6.5.3 Terumo Corporation Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Corporation Extracorporeal Membrane Oxygenation System Product Portfolio
6.5.5 Terumo Corporation Recent Developments/Updates
6.6 MicroPort Scientific Corporation
6.6.1 MicroPort Scientific Corporation Corporation Information
6.6.2 MicroPort Scientific Corporation Description and Business Overview
6.6.3 MicroPort Scientific Corporation Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MicroPort Scientific Corporation Extracorporeal Membrane Oxygenation System Product Portfolio
6.6.5 MicroPort Scientific Corporation Recent Developments/Updates
6.7 NIPRO Corporation
6.6.1 NIPRO Corporation Corporation Information
6.6.2 NIPRO Corporation Description and Business Overview
6.6.3 NIPRO Corporation Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NIPRO Corporation Extracorporeal Membrane Oxygenation System Product Portfolio
6.7.5 NIPRO Corporation Recent Developments/Updates
6.8 OriGen Biomedical
6.8.1 OriGen Biomedical Corporation Information
6.8.2 OriGen Biomedical Description and Business Overview
6.8.3 OriGen Biomedical Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 OriGen Biomedical Extracorporeal Membrane Oxygenation System Product Portfolio
6.8.5 OriGen Biomedical Recent Developments/Updates
6.9 ALung Technologies
6.9.1 ALung Technologies Corporation Information
6.9.2 ALung Technologies Description and Business Overview
6.9.3 ALung Technologies Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ALung Technologies Extracorporeal Membrane Oxygenation System Product Portfolio
6.9.5 ALung Technologies Recent Developments/Updates
6.10 EUROSETS S.r.l.
6.10.1 EUROSETS S.r.l. Corporation Information
6.10.2 EUROSETS S.r.l. Description and Business Overview
6.10.3 EUROSETS S.r.l. Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 EUROSETS S.r.l. Extracorporeal Membrane Oxygenation System Product Portfolio
6.10.5 EUROSETS S.r.l. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracorporeal Membrane Oxygenation System Industry Chain Analysis
7.2 Extracorporeal Membrane Oxygenation System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracorporeal Membrane Oxygenation System Production Mode & Process
7.4 Extracorporeal Membrane Oxygenation System Sales and Marketing
7.4.1 Extracorporeal Membrane Oxygenation System Sales Channels
7.4.2 Extracorporeal Membrane Oxygenation System Distributors
7.5 Extracorporeal Membrane Oxygenation System Customers
8 Extracorporeal Membrane Oxygenation System Market Dynamics
8.1 Extracorporeal Membrane Oxygenation System Industry Trends
8.2 Extracorporeal Membrane Oxygenation System Market Drivers
8.3 Extracorporeal Membrane Oxygenation System Market Challenges
8.4 Extracorporeal Membrane Oxygenation System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
